He has been engaged in medical work for 29 years, and has studied and worked in the First Internal Medicine Department of Kyushu University in Japan and the former Internal Medicine Department of Nagasaki University in Japan for 8 years. He is good at the diagnosis and treatment of hematological diseases, especially hematological tumors such as leukemia and malignant lymphoma. As the president of the conference, he presided over the 4th National Cancer Conference and the 1st Guangzhou Cancer Conference of China Cancer Research Foundation. Published more than 60 papers/kloc-0 in academic journals at home and abroad. Editor-in-Chief: Modern Hematopoietic Stem Cell Transplantation, Cancer Research Progress in China, 400 Answers to Cancer Prevention and Treatment, etc. Deputy editor: hematology laboratory and clinic: 1 monograph; He also participated in the compilation of 8 monographs such as Clinical Blood Transfusion, a textbook for national medical colleges. Undertake 26 scientific research fund projects at or above the provincial and ministerial level, such as climbing special sub-projects of the Ministry of Science and Technology. Three doctoral students and 14 master students have been trained. Now he is the academic and technical leader of Guangdong health system (the "Five Ones Project" of Guangdong Health Department to promote medicine through science and education).

Representative research projects:

1, basic research on hematopoietic stem cell engineering

2. Induction and differentiation of embryonic stem cells and umbilical cord blood hematopoietic stem cells, and early diagnosis and comprehensive prevention of refractory leukemia.

3. Stem cell mobilization and transplantation for myocardial infarction.

4. Study on the effect of umbilical cord blood endothelial progenitor cells on myocardial fibrosis and angiogenesis.

5. The oligonucleotide aptamer of leukemia stem cell surface marker CD 123 was screened and purified to 40,000 yuan (2008 -20 10).

Representative academic works:

1, modern hematopoietic stem cell transplantation. First edition. Guangzhou: Guangdong Science and Technology Press, 2004.

2. Targeted therapy of leukemia stem cells. China Journal of Oncology, 2006,28 (6): 401-403.

3. Biological characteristics and targeted therapy of tumor stem cells. Cancer research and clinic, 2007,19 (3):145-147.

4. The serum of rats with myocardial infarction can promote the differentiation of bone marrow mesenchymal stem cells into cardiomyocytes. China Journal of Pathophysiology, 2007,23 (5): 853-857.

5. The new target of tumor therapy-tumor stem cells. China cancer. 2007, 16(7):5 18-520.